FDA Inspection 1161858 — Adam Horvit, M.D.
The FDA completed an inspection of Adam Horvit, M.D. on February 2, 2022 in Round Rock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 2, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Round Rock, TX (United States)
Additional Details
Clinical Investigator (CI)